BRPI0922821A2 - processo de fabricação de micropartículas de liberação sustentada - Google Patents

processo de fabricação de micropartículas de liberação sustentada

Info

Publication number
BRPI0922821A2
BRPI0922821A2 BRPI0922821A BRPI0922821A BRPI0922821A2 BR PI0922821 A2 BRPI0922821 A2 BR PI0922821A2 BR PI0922821 A BRPI0922821 A BR PI0922821A BR PI0922821 A BRPI0922821 A BR PI0922821A BR PI0922821 A2 BRPI0922821 A2 BR PI0922821A2
Authority
BR
Brazil
Prior art keywords
manufacturing process
sustained release
release microparticle
microparticle manufacturing
sustained
Prior art date
Application number
BRPI0922821A
Other languages
English (en)
Inventor
Bagavathikanun Chithambara Thanoo
Byung Ho Woo
Gonto Johns Iii
Original Assignee
Oakwood Lab Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42231354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0922821(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oakwood Lab Llc filed Critical Oakwood Lab Llc
Publication of BRPI0922821A2 publication Critical patent/BRPI0922821A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922821A 2008-12-04 2009-12-01 processo de fabricação de micropartículas de liberação sustentada BRPI0922821A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/328,136 US20100143479A1 (en) 2008-12-04 2008-12-04 Method of making sustained release microparticles
PCT/US2009/066212 WO2010065513A1 (en) 2008-12-04 2009-12-01 Method of making sustained release microparticles

Publications (1)

Publication Number Publication Date
BRPI0922821A2 true BRPI0922821A2 (pt) 2015-12-22

Family

ID=42231354

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922821A BRPI0922821A2 (pt) 2008-12-04 2009-12-01 processo de fabricação de micropartículas de liberação sustentada

Country Status (9)

Country Link
US (2) US20100143479A1 (pt)
EP (1) EP2379055B1 (pt)
JP (1) JP6172887B2 (pt)
CN (1) CN102271660B (pt)
BR (1) BRPI0922821A2 (pt)
CA (2) CA2765695C (pt)
ES (1) ES2655890T3 (pt)
MX (1) MX340458B (pt)
WO (1) WO2010065513A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471303A (en) 2009-06-24 2010-12-29 Bell Flavors & Fragrances Duft Und Aroma Gmbh Microparticles and method of making microparticles
CN203042961U (zh) * 2012-01-10 2013-07-10 山东绿叶制药有限公司 一种连续生产微球的设备
JP6135292B2 (ja) * 2013-05-10 2017-05-31 ニプロ株式会社 マイクロカプセル製剤の製造方法
JP2016102093A (ja) * 2014-11-28 2016-06-02 ニプロ株式会社 塩基性の求核化合物を含有するマイクロカプセルの製造方法
US10441548B2 (en) 2015-11-12 2019-10-15 Graybug Vision, Inc. Aggregating microparticles for medical therapy
US20190380967A1 (en) * 2017-01-23 2019-12-19 Savior Lifetec Corporation Preparation of microparticles of an active ingredient
MX2019011242A (es) 2017-03-23 2020-01-21 Graybug Vision Inc Farmacos y composiciones para el tratamiento de trastornos oculares.
MX2019013363A (es) 2017-05-10 2020-01-13 Graybug Vision Inc Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
HUE062719T2 (hu) 2018-06-29 2023-11-28 Akston Biosciences Corp Ultra-hosszú hatású inzulin-FC fúziós fehérjék és az alkalmazási eljárások
WO2021199077A1 (en) 2020-03-30 2021-10-07 Biological E Limited Risperidone microspheres, process for their prepartion and uses thereof
EP4598504A2 (en) 2022-10-05 2025-08-13 Mireca Medicines GmbH Microparticle and implant formulations for cgmp analog therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
US6270802B1 (en) * 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
US6705757B2 (en) * 1999-11-12 2004-03-16 Alkermes Controlled Therapeutics, Inc. Ii Method and apparatus for preparing microparticles using in-line solvent extraction
US6495166B1 (en) 1999-11-12 2002-12-17 Alkermes Controlled Therapeutics Inc. Apparatus and method for preparing microparticles using in-line solvent extraction
US20070207211A1 (en) * 2003-04-10 2007-09-06 Pr Pharmaceuticals, Inc. Emulsion-based microparticles and methods for the production thereof
EP1660039B1 (en) * 2003-07-18 2016-09-28 Oakwood Laboratories L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions

Also Published As

Publication number Publication date
MX2011005904A (es) 2011-09-27
JP2012511003A (ja) 2012-05-17
JP6172887B2 (ja) 2017-08-02
EP2379055A4 (en) 2012-06-13
US20180177785A1 (en) 2018-06-28
MX340458B (es) 2016-07-08
CA2745784A1 (en) 2010-06-10
ES2655890T3 (es) 2018-02-22
US20100143479A1 (en) 2010-06-10
CN102271660B (zh) 2018-04-06
CA2765695C (en) 2018-01-02
WO2010065513A1 (en) 2010-06-10
EP2379055B1 (en) 2017-11-08
CA2765695A1 (en) 2010-06-10
CN102271660A (zh) 2011-12-07
EP2379055A1 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
BRPI0821944A2 (pt) Processo
BRPI0919868A2 (pt) processo
BRPI0921374A2 (pt) processo
BRPI0913843A2 (pt) processo de granulação por fusão
BRPI0916479A2 (pt) Processo de fabricação de artigo moldado e artigo moldado
BRPI0914675A2 (pt) processo de secagem por atomização
BRPI0914670A2 (pt) processo de secagem por atomização
SMT201400100B (it) Processo migliorato
BR112012000822A2 (pt) processo
BRPI0910033A2 (pt) processo para a modificação de superfícies de partículas
BRPI0809681A2 (pt) processo para fabricação de polímeros
BRPI0816478A2 (pt) Processo para produção de celulases
BRPI0910662A2 (pt) processo para modificação de superfície de partículas
PT2165971T (pt) Processo de hidrotratamento
BR112012012338A2 (pt) processo
BR112012000821A2 (pt) "processo"
BRPI0814291A2 (pt) Processo para produção de alcoóis
BRPI0908725A2 (pt) Processo enzimático
BRPI1006478A2 (pt) processo de fabricação de poliamida
BRPI0914221A2 (pt) processo, e, composto
BRPI0806503A2 (pt) Processo aperfeiçoado de secagem por pulverização
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0919241A2 (pt) processo de fabricação de compostos de quinolona
BR112012014943A2 (pt) processo de secagem por atomização
BRPI0806679A2 (pt) Processo aperfeiçoado de produção de alquilaromático

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2647 DE 28-09-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.